Schizophrenia Research
Volume 76, Issue 2 , Pages 247-265, 15 July 2005

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

  • Guy Chouinard

      Affiliations

    • Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West, Montreal, QC, Canada, H3A 1A1
    • Fernand-Seguin Research Centre, Louis-H. Lafontaine Hospital, Montreal and Department of Psychiatry University of Montreal, Montreal, QC, Canada, H1N 3M5
    • Corresponding Author InformationCorresponding author. Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West, Montreal, QC, Canada, H3A 1A1. Tel.: +1 514 843 1672; fax: +1 514 982 6620.
  • ,
  • Howard C. Margolese

      Affiliations

    • Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West, Montreal, QC, Canada, H3A 1A1

Received 16 September 2004; received in revised form 18 February 2005; accepted 21 February 2005.

Abstract 

The Extrapyramidal Symptom Rating Scale (ESRS) was developed to assess four types of drug-induced movement disorders (DIMD): Parkinsonism, akathisia, dystonia, and tardive dyskinesia (TD). Comprehensive ESRS definitions and basic instructions are given.

Factor analysis provided six ESRS factors: 1) hypokinetic Parkinsonism; 2) orofacial dyskinesia; 3) trunk/limb dyskinesia; 4) akathisia; 5) tremor; and 6) tardive dystonia. Two pivotal studies found high inter-rater reliability correlations in both antipsychotic-induced movement disorders and idiopathic Parkinson disease.

For inter-rater reliability and certification of raters, ≥80% of item ratings of the complete scale should be ±1 point of expert ratings and ≥70% of ratings on individual items of each ESRS subscale should be ±1 point of expert ratings.

During a cross-scale comparison, AIMS and ESRS were found to have a 96% (359/374) agreement between TD-defined cases by DSM-IV TD criteria. Two recent international studies using the ESRS included over 3000 patients worldwide and showed an incidence of TD ranging from 10.2% (2000) to 12% (1998).

ESRS specificity was investigated through two different approaches, path analyses and ANCOVA PANSS factors changes, which found that ESRS measurement of drug-induced EPS is valid and discriminative from psychiatric symptoms.

Keywords: Extrapyramidal symptoms, Parkinsonism, Tardive dyskinesia, Movement disorders, Dystonia, Antipsychotic, Neuroleptic, Drug-induced movement disorders, Rating scale, Schizophrenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(05)00078-2

doi:10.1016/j.schres.2005.02.013

Refers to erratum:

  • Erratum to “Manual for the Extrapyramidal Symptom Rating Scale (ESRS)” [Schizophrenia Research 76 (2–3) (2005) 247–265]

    Guy Chouinard, Howard C. Margolese
    Schizophrenia Research July 2006 (Vol. 85, Issue 1, Page 305)

Schizophrenia Research
Volume 76, Issue 2 , Pages 247-265, 15 July 2005